BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 23, 2004
View Archived Issues
La Jolla Raises $27M Following FDA Acceptance Of Riquent NDA
Read More
Graffinity Raises EUR15M In Third Round For Discovery Programs
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
U.S. Patent Disclosures
Read More
Facing Rising Costs For Clinical Trials, Rigel Offering Raises $57M
Raking in net proceeds of $57 million, Rigel Pharmaceuticals Inc. more than doubled its cash reserves after pricing a common stock offering. (BioWorld Today)
Read More
FDA Losing Chief: Bush Taps McClellan As Leader Of CMS
Read More